Proceedings: Clinical studies of dopaminergic mechanisms.
D000978:Antiparkinson Agents / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004149:Dioxoles / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011955:Receptors, Drug / Q000187:drug effects
D000978:Antiparkinson Agents; D004149:Dioxoles; D010879:Piperazines; D011743:Pyrimidines; D011955:Receptors, Drug; D004295:Dihydroxyphenylalanine; D006220:Haloperidol; D004298:Dopamine; D006719:Homovanillic Acid